| 2001 |
Bif-1 (SH3GLB1) was identified as a novel Bax-binding protein via yeast two-hybrid cloning. It contains an SH3 domain near its C-terminus and interacts with Bax as confirmed by coimmunoprecipitation and immunofluorescence. Overexpression of Bif-1 promotes Bax conformational change, caspase activation, and apoptotic cell death in FL5.12 cells following IL-3 deprivation. |
Yeast two-hybrid, coimmunoprecipitation, immunofluorescence, overexpression in FL5.12 cells |
The Journal of biological chemistry |
High |
11259440
|
| 2005 |
Endogenous Bif-1 is required for conformational change of both Bax and Bak, cytochrome c release, and caspase-3 activation during intrinsic apoptosis. Bif-1 heterodimerizes with Bax on mitochondria in intact cells, and this interaction is enhanced by apoptosis induction and precedes Bax conformational change. While Bif-1 did not directly interact with Bak, it plays a regulatory role in Bak activation. |
RNAi knockdown in HeLa cells, Bif-1 knockout MEFs, coimmunoprecipitation, apoptosis assays (cytochrome c release, caspase-3 activation), soft-agar and nude-mouse tumorigenesis assays |
Molecular and cellular biology |
High |
16227588
|
| 2007 |
Bif-1 interacts with Beclin 1 through UVRAG and functions as a positive mediator of the class III PI3-kinase (PI3KC3/VPS34). Both the BAR and SH3 domains are required for Bif-1 to activate PI3KC3 and induce autophagosome formation, while the SH3 domain alone is sufficient for binding to UVRAG. Upon nutrient deprivation, Bif-1 localizes to autophagosomes co-localizing with Atg5 and LC3. Loss of Bif-1 suppresses autophagosome formation and promotes spontaneous tumor development in mice. |
Coimmunoprecipitation, domain-deletion mutants, siRNA knockdown, immunofluorescence colocalization, Bif-1 knockout mouse tumorigenesis assay |
Nature cell biology |
High |
17891140
|
| 2008 |
Bif-1 N-BAR domain stimulates BAX-driven mitochondrial outer membrane permeabilization (MOMP) and BAX conformational activation in a reconstituted system with purified proteins and MOM-like liposomes. This process requires physical interaction between Bif-1 N-BAR and BAX and the presence of cardiolipin. Large-scale membrane morphological rearrangements induced by Bif-1 N-BAR could be separated from functional BAX activation. DLP1/Drp1 caused global morphological changes in MOM-like liposomes but did not stimulate BAX-permeabilizing function. |
In vitro reconstitution with purified proteins and MOM-like liposomes, domain mutagenesis (N-BAR domain), cardiolipin-dependence assay, MOMP measurement |
The Journal of biological chemistry |
High |
19074440
|
| 2008 |
c-Src kinase binds to Bif-1 and directly phosphorylates it on tyrosine 80. Src phosphorylation of Bif-1 suppresses its interaction with Bax, inhibiting Bax activation during anoikis. Apoptotic stimuli repress this phosphorylation event. |
Kinase assay, site-directed mutagenesis (Y80), coimmunoprecipitation, anoikis assay |
The Journal of biological chemistry |
High |
18474606
|
| 2010 |
A specific PI3K-III sub-complex containing VPS15, VPS34, Beclin 1, UVRAG and BIF-1 (but not ATG14L) regulates both receptor degradation and cytokinesis. UVRAG and BIF-1 localize strongly to the midbody, supporting an unanticipated role of BIF-1 in cytokinesis. |
siRNA-mediated depletion of individual subunits, high-content microscopy-based assays for receptor degradation and cytokinesis, immunofluorescence localization to midbody |
Experimental cell research |
Medium |
20643123
|
| 2010 |
GSK-3β inhibition results in elevation of Bif-1 protein levels, and silencing Bif-1 abrogates the GSK-3β-inhibition-induced autophagic response and necrotic cell death under serum starvation. This places Bif-1 downstream of GSK-3β in regulating autophagy and cell survival. |
GSK-3β chemical inhibitors and siRNA, Bif-1 siRNA silencing, cell death assays (morphology and biochemical markers), western blotting |
Journal of cell science |
Medium |
20159967
|
| 2011 |
Bif-1 is required for Atg9 trafficking and fission of Golgi membranes during autophagy induction. Upon starvation, Atg9-positive membranes undergo tubulation and fragmentation to produce punctate structures positive for Rab5, Atg16L, and LC3. Loss of Bif-1 suppresses starvation-induced Golgi membrane fission and peripheral redistribution of Atg9. Bif-1 mutants lacking functional N-BAR domain regions (membrane binding/bending) fail to restore Golgi fission, Atg9 foci, and autophagosome formation in Bif-1-deficient cells. |
Loss-of-function (siRNA/KO), N-BAR domain mutants, live-cell fluorescence microscopy of Atg9 trafficking, Golgi morphology assays |
Autophagy |
High |
21068542
|
| 2012 |
Bif-1 promotes EGFR endocytic degradation in breast cancer cells. Loss of Bif-1 delays EGFR degradation, sequesters internalized EGF in Rab5-positive endosomes, impairs Rab7 recruitment and activation, and alters intracellular pH and acidic vesicle localization. This results in sustained Erk1/2 activation and increased EGF-stimulated chemotactic cell migration. |
siRNA knockdown, EGFR degradation assay, Rab5/Rab7 colocalization by immunofluorescence, Erk1/2 activation by western blot, chemotaxis assay, EGFR inhibitor (gefitinib) rescue |
Cancer biology & therapy |
Medium |
22785202
|
| 2013 |
Bif-1 is indispensable for autophagy-dependent clearance of damaged mitochondria (mitophagy). Loss of Bif-1 causes accumulation of ER-associated immature autophagosomes and suppresses autophagosome maturation. At the premalignant stage, allelic loss of Bif-1 increases mitochondrial mass, accumulation of DNA damage, and upregulation of Mcl-1, linking impaired mitophagy to chromosomal instability and apoptosis resistance during Myc-driven lymphomagenesis. |
Bif-1 KO/haploinsufficient mice with Eμ-Myc transgene, CCCP-treated PARK2-expressing MEFs, electron microscopy of autophagosome morphology, mitochondrial mass assays, immunoblotting for Mcl-1/Bcl-xl, caspase-3 activation assay |
Blood |
High |
23287860 23680845
|
| 2013 |
SH3GLB1 (Bif-1) is present on endo/lysosomal carriers of nicotinic acetylcholine receptors (CHRN) at the neuromuscular junction during fasting-induced muscle atrophy, together with TRIM63 and SQSTM1, and these vesicles are surrounded by the autophagic marker MAP1LC3A in an ATG7-dependent fashion, indicating SH3GLB1 participates in selective autophagy-mediated CHRN turnover. |
In vivo mouse studies (denervation, fasting), ATG7 KO, TRIM63 KO, immunofluorescence colocalization, co-precipitation of SQSTM1/LC3-II with CHRN |
Autophagy |
Medium |
24220501
|
| 2016 |
Bif-1 interacts with Dynamin 2 (DNM2) and this interaction is enhanced upon nutrient starvation. Bif-1 and DNM2 cooperatively induce the generation of Atg9-containing vesicles from a Rab11-positive reservoir. Inhibition of DNM2 GTPase activity causes accumulation of Atg9-positive tubular structures from this reservoir. Atg9 trafficking to the Rab11-positive reservoir is constitutive and independent of Bif-1, but membrane tubulation from the reservoir requires Bif-1. |
Coimmunoprecipitation, DNM2 GTPase inhibitor, live-cell fluorescence microscopy, Bif-1 KO rescue experiments, Rab11 colocalization |
Oncotarget |
Medium |
26980706
|
| 2016 |
Threonine-145 phosphorylation of SH3GLB1 regulates CHRN (nicotinic acetylcholine receptor) endocytic trafficking at neuromuscular junctions. Phosphomimetic T145E mutant slows processing of endocytic CHRN vesicles, while phosphodeficient T145A augments it. Co-expression of RAB5 largely rescued the slow processing induced by T145E. SH3GLB1 phosphomutants alter the expression of RAB5 activity regulators. |
Overexpression of T145E/T145A phosphomutants in vivo at mouse NMJs, CHRN vesicle tracking, RAB5 co-expression rescue experiments, immunofluorescence |
Autophagy |
Medium |
27715385
|
| 2016 |
Bif-1 deficiency reduces the basal rate of adipose tissue lipolysis, causes adipocyte hypertrophy, and attenuates fasting/refeeding-induced lipid droplet clearance in the liver, demonstrating a role for Bif-1 in regulating lipid catabolism and preventing obesity. Bif-1 loss also downregulates Atg9a and Lamp1 in adipose tissue. |
Bif-1 KO mice (aging and high-fat diet challenge), adipose tissue histology, lipolysis assays, liver lipid droplet clearance assay, western blotting for autophagy-lysosomal proteins |
Scientific reports |
Medium |
26857140
|
| 2017 |
Calpain (activated via CAPNS1) enables dynamic flux of Atg9/Bif-1-containing vesicles from Golgi stacks toward the budding autophagosome. CAPNS1 depletion causes Atg9 and Bif-1 to remain in GM130-positive Golgi stacks, prevents Atg9 interaction with Vps34 and transferrin receptor, and causes LC3 body/Rab5 early endosome accumulation. A calpain-cleavage-resistant Bif-1 point mutant causes accumulation of p62 and LC3-II. |
CAPNS1 siRNA depletion, calpain-resistant Bif-1 point mutant overexpression, coimmunoprecipitation (Atg9-Vps34), immunofluorescence colocalization of Atg9/Bif-1 with Golgi/LC3 markers |
Biology open |
Medium |
28302665
|
| 2018 |
The RNA splicing factor SRRM4 promotes alternative splicing of the Bif-1 gene, producing neural-specific isoforms Bif-1b and Bif-1c in treatment-induced neuroendocrine prostate cancer. The predominant variant Bif-1a is pro-apoptotic, whereas Bif-1b and Bif-1c are anti-apoptotic in PCa cells under camptothecin and UV treatment. |
Transcriptome comparison, SRRM4 overexpression and knockdown, isoform-specific apoptosis assays (camptothecin/UV treatment) |
EBioMedicine |
Medium |
29759485
|
| 2019 |
Upon cell stress, Bif-1 translocates to mitochondria and binds prohibitin-2 via its C-terminus (specifically requiring tryptophan-344), resulting in disruption of the prohibitin complex and proteolytic inactivation/cleavage of the inner membrane fusion protein OPA1, promoting mitochondrial fragmentation and apoptosis. Bif-1 deficiency inhibits prohibitin complex disruption, OPA1 proteolysis, and mitochondrial fragmentation. In vivo, Bif-1 bound prohibitin-2 during renal ischemia/reperfusion injury, and Bif-1 KO protected against OPA1 proteolysis, fragmentation, and kidney injury. |
Coimmunoprecipitation, domain-deletion analysis, W344 point mutant, Bif-1 KO mice (renal ischemia/reperfusion model), MEFs, mitochondrial fractionation, OPA1 proteolysis assays |
Journal of the American Society of Nephrology : JASN |
High |
31126972
|
| 2022 |
SUMO2-mediated SUMOylation of SH3GLB1 at lysine 82 is promoted by ionizing radiation, as shown by co-IP and laser confocal colocalization of SUMO2 and SH3GLB1. IR promotes interactions between SH3GLB1 and mitochondrial membrane proteins MFN1/2, TOM20, and Drp1. SH3GLB1 deficiency inhibits mitophagy activation and restores mitochondrial cristae. |
Bioinformatics prediction of SUMOylation site (K82), coimmunoprecipitation, laser confocal microscopy colocalization, SH3GLB1 KO in cardiomyocytes and in vivo IR model |
European journal of pharmacology |
Medium |
35487252
|
| 2025 |
SH3GLB1 is required for the nuclear localization of the NOTCH2 intracellular domain (N2ICD) and NOTCH2 signaling activation in glioblastoma. Genetic depletion of SH3GLB1 impairs N2ICD nuclear localization, reduces tumorigenic potential, and impairs tumor growth in vivo. |
SH3GLB1 genetic depletion, N2ICD nuclear localization assay, in vivo tumor growth assay |
Biochemical and biophysical research communications |
Low |
40639082
|
| 2025 |
Affinity-based protein profiling using a fentanyl-derived probe identified SH3GLB1 (endophilin-B1) as a protein that physically binds fentanyl in vitro across multiple species and tissue types, with molecular docking identifying putative binding sites. |
Affinity-based protein profiling with photoaffinity probe, click chemistry, molecular docking |
bioRxivpreprint |
Low |
bio_10.1101_2025.02.20.634605
|